The Cystic Fibrosis Foundation presents seven evidence-based recommendations to improve newborn screening for cystic fibrosis in the United States. These guidelines aim to enhance sensitivity, equity, and timeliness by refining IRT cutoff strategies, expanding CFTR variant panels, and improving communication with care teams.
The Cystic Fibrosis Foundation has developed consensus recommendations for delivering palliative care to individuals with cystic fibrosis. These evidence-informed guidelines address primary and specialty palliative care models, screening for palliative needs, and strategies to improve quality of life across all stages of illness.
The spectrum of conditions caused by abnormal CFTR function is broad – from ‘classic’ cystic fibrosis (CF) to single organ conditions termed CFTR-related disorders.
The Cystic Fibrosis Foundation has released evidence-based guidelines for managing CRMS/CFSPID, a designation for infants with inconclusive cystic fibrosis screening results. Developed by a multidisciplinary panel, the recommendations address genetic testing, monitoring, treatment, and communication strategies, with an emphasis on shared decision-making and minimizing unnecessary interventions.
Purpose of review: Due to continuous development of new drugs and better treatment strategies, survival of patients with cystic fibrosis has changed dramatically.
The past six decades have seen remarkable improvements in health outcomes for people with cystic fibrosis, which was once a fatal disease of infants and young children. However, although life expectancy for people with cystic fibrosis...
Newborn screening for cystic fibrosis (CF) has become a widely accepted and endorsed public health strategy in economically developed countries, although there is little consensus on optimal screening methods and gene panels.
This review highlights the importance of preventing malnutrition in cystic fibrosis (CF) patients, discussing recent findings on nutrition, the role of specific nutrients, exercise, and novel treatments like CFTR modulators.
Physical activity (PA) is important in the management of Cystic Fibrosis (CF) and is associated with a number of beneficial effects. PA assessment is not commonplace or consistent in clinical practice...
CFTR has mainly been studied in epithelial cells although it is also functional and expressed in other cell types including endothelial cells. The present review summarizes current knowledge on the role of the endothelium in CF.